Unknown

Dataset Information

0

The Assessment of the Readiness of Molecular Biomarker-Based Mobile Health Technologies for Healthcare Applications.


ABSTRACT: Mobile health technologies to detect physiological and simple-analyte biomarkers have been explored for the improvement and cost-reduction of healthcare services, some of which have been endorsed by the US FDA. Advancements in the investigations of non-invasive and minimally-invasive molecular biomarkers and biomarker candidates and the development of portable biomarker detection technologies have fuelled great interests in these new technologies for mhealth applications. But apart from the development of more portable biomarker detection technologies, key questions need to be answered and resolved regarding to the relevance, coverage, and performance of these technologies and the big data management issues arising from their wide spread applications. In this work, we analyzed the newly emerging portable biomarker detection technologies, the 664 non-invasive molecular biomarkers and the 592 potential minimally-invasive blood molecular biomarkers, focusing on their detection capability, affordability, relevance, and coverage. Our analysis suggests that a substantial percentage of these biomarkers together with the new technologies can be potentially used for a variety of disease conditions in mhealth applications. We further propose a new strategy for reducing the workload in the processing and analysis of the big data arising from widespread use of mhealth products, and discuss potential issues of implementing this strategy.

SUBMITTER: Qin C 

PROVIDER: S-EPMC4672303 | biostudies-other | 2015 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

The Assessment of the Readiness of Molecular Biomarker-Based Mobile Health Technologies for Healthcare Applications.

Qin Chu C   Tao Lin L   Phang Yik Hui YH   Zhang Cheng C   Chen Shang Ying SY   Zhang Peng P   Tan Ying Y   Jiang Yu Yang YY   Chen Yu Zong YZ  

Scientific reports 20151208


Mobile health technologies to detect physiological and simple-analyte biomarkers have been explored for the improvement and cost-reduction of healthcare services, some of which have been endorsed by the US FDA. Advancements in the investigations of non-invasive and minimally-invasive molecular biomarkers and biomarker candidates and the development of portable biomarker detection technologies have fuelled great interests in these new technologies for mhealth applications. But apart from the deve  ...[more]

Similar Datasets

| S-EPMC10860469 | biostudies-literature
| S-EPMC8274877 | biostudies-literature
| S-EPMC6710110 | biostudies-literature
| S-EPMC9263958 | biostudies-literature
| S-EPMC7392241 | biostudies-literature
| S-EPMC7065029 | biostudies-literature
| S-EPMC7160700 | biostudies-literature
| S-EPMC7688390 | biostudies-literature
| S-EPMC6041558 | biostudies-literature